Handok (KO:002390) — Market Cap & Net Worth
Market Cap & Net Worth: Handok (002390)
Handok (KO:002390) has a market capitalization of $90.77 Million (₩133.94 Billion) as of May 5, 2026. Listed on the KO stock exchange, this Korea-based company holds position #19561 globally and #1100 in its home market, demonstrating a -0.29% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Handok's stock price ₩10310.00 by its total outstanding shares 12990956 (12.99 Million). Analyse Handok (002390) cash conversion ratio to see how efficiently the company converts income to cash.
Handok Market Cap History: 2015 to 2026
Handok's market capitalization history from 2015 to 2026. Data shows change from $236.21 Million to $90.77 Million (-6.87% CAGR).
Handok Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Handok's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Handok's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $236.21 Million | $358.45 Billion | -$1.69 Billion | 0.00x | N/A |
| 2016 | $212.28 Million | $396.13 Billion | -$6.45 Billion | 0.00x | N/A |
| 2017 | $269.26 Million | $417.97 Billion | $4.87 Billion | 0.00x | 0.06x |
| 2018 | $254.34 Million | $446.73 Billion | $7.99 Billion | 0.00x | 0.03x |
| 2019 | $189.97 Million | $473.00 Billion | $34.93 Billion | 0.00x | 0.01x |
| 2020 | $281.88 Million | $503.61 Billion | $26.96 Billion | 0.00x | 0.01x |
| 2021 | $196.02 Million | $517.64 Billion | $3.29 Billion | 0.00x | 0.06x |
| 2022 | $147.46 Million | $543.76 Billion | $10.68 Billion | 0.00x | 0.01x |
| 2023 | $125.89 Million | $522.74 Billion | -$28.80 Billion | 0.00x | N/A |
| 2024 | $106.09 Million | $507.36 Billion | -$52.56 Billion | 0.00x | N/A |
Competitor Companies of 002390 by Market Capitalization
Companies near Handok in the global market cap rankings as of May 5, 2026.
Key companies related to Handok by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #499 globally with a market cap of $52.60 Billion USD.
- Zoetis Inc (NYSE:ZTS): Ranked #525 globally with a market cap of $50.31 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #526 globally with a market cap of $50.29 Billion USD ( CN¥343.70 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #572 globally with a market cap of $45.88 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #499 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #525 | Zoetis Inc | NYSE:ZTS | $50.31 Billion | $114.16 |
| #526 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.29 Billion | CN¥53.88 |
| #572 | GALDERMA GROUP AG | NYSE:GALDY | $45.88 Billion | $42.15 |
Handok Historical Marketcap From 2015 to 2026
Between 2015 and today, Handok's market cap moved from $236.21 Million to $ 90.77 Million, with a yearly change of -6.87%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩90.77 Million | -7.95% |
| 2025 | ₩98.60 Million | -7.05% |
| 2024 | ₩106.09 Million | -15.73% |
| 2023 | ₩125.89 Million | -14.63% |
| 2022 | ₩147.46 Million | -24.77% |
| 2021 | ₩196.02 Million | -30.46% |
| 2020 | ₩281.88 Million | +48.38% |
| 2019 | ₩189.97 Million | -25.31% |
| 2018 | ₩254.34 Million | -5.54% |
| 2017 | ₩269.26 Million | +26.84% |
| 2016 | ₩212.28 Million | -10.13% |
| 2015 | ₩236.21 Million | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of Handok was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $90.77 Million USD |
| MoneyControl | $90.77 Million USD |
| MarketWatch | $90.77 Million USD |
| marketcap.company | $90.77 Million USD |
| Reuters | $90.77 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Handok
HANDOK Inc. operates as a pharmaceutical company. The company provides prescription and OTC drugs; medical devices, such as blood pressure monitors, cholesterol monitoring systems, insulin pumps, self-monitoring system of blood glucose, and blood glucose monitoring system; in vitro diagnostic medical devices; as well as life science products. It also offers healthcare products comprising food sup… Read more